DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY

Clinical trials for DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY explained in plain language.

Never miss a new study

Get alerted when new DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY trials appear

Sign up with your email to follow new studies for DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

One-of-a-Kind drug created for single Patient's devastating genetic illness

Disease control Not yet recruiting

This study is creating a custom drug for one person with a rare, inherited brain disease called DRPLA. The goal is to see if this personalized treatment is safe and can help control the patient's seizures and other symptoms. Researchers will closely monitor the patient's health a…

Matched conditions: DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY

Phase: PHASE1, PHASE2 • Sponsor: n-Lorem Foundation • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY

Get alerted when new DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY trials appear

One-of-a-Kind drug created for single Patient's devastating genetic illness